Shape and firmness, not size — poly-L-lactic acid in the fat layer, where your collagen builds over months. Buttock use of Sculptra® is off-label, and we say so here before you read another line.
Book a consultationContour, not size
A Sculptra® butt lift is injectable poly-L-lactic acid placed in subcutaneous fat, where your body builds its own collagen. Plans run 3 to 4 sessions, 6 to 8 weeks apart, with change appearing between month 3 and month 6. Buttock use is off-label, and the result is contour rather than size.
Most who ask have ruled out surgery. A Sculptra® butt lift is poly-L-lactic acid placed in the fat over the buttock, where your collagen builds. The material leaves; what it prompted stays.
Sculptra® is approved by the U.S. Food and Drug Administration for facial fat loss in people with HIV, and Sculptra® Aesthetic is approved for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles, with cheek wrinkles added in 2023, in immune-competent people, which means people whose immune system is working normally. Both approvals are facial, so treating the buttock is an off-label use, which means the FDA has not reviewed that particular use: the product is the same, and the indication has not been through approval. A surgical Brazilian butt lift moves the patient's own fat under anesthesia, and BBL® is separately a registered trademark of Sciton, Inc. for a light-based device that involves no injection at all.
What changes is the surface: how light falls, and how firm the skin feels. Microparticles fan through the subcutaneous fat, where fibroblasts lay down type I collagen.
| Approach | What is placed | Plane | Time to visible change | Typical duration | Reversible | U.S. regulatory status for the buttock |
|---|---|---|---|---|---|---|
| Sculptra® (poly-L-lactic acid) | PLLA microparticles suspended in sterile water | Subcutaneous fat, above the muscle | 6 weeks to 6 months | Facial data to about 25 months; buttock durability not established | No | Off-label. Approved for facial use only |
| Surgical fat transfer (Brazilian butt lift) | Your own fat, harvested by liposuction | Subcutaneous fat; intramuscular placement is where fatal embolism risk sits | Immediate, settling over 3 to 6 months | Long-term for the fat that survives; retention varies widely between patients | No | A surgical procedure performed by a surgeon, not a device indication |
| Hyaluronic acid body filler | Cross-linked hyaluronic acid gel | Subcutaneous fat | Immediate | Product-dependent; not established for the buttock | Yes, with hyaluronidase | Off-label. No hyaluronic acid filler is approved for buttock augmentation |
| Liquid silicone or “biopolymer” injection | Unapproved liquid silicone or industrial polymer | Migrates across tissue planes over time | Immediate | Does not resorb; complications can appear decades later | No | Not approved and not legal for this use. Referral rather than treatment |
Two variables decide between these: how much volume your goal needs, and whether it must be reversible. Figures reflect product labeling, published facial data and practice observation. No injectable is FDA-approved for buttock augmentation, and the FDA has issued a safety communication advising against injectable filler for large-scale body contouring.
Sculptra® (injectable poly-L-lactic acid) — Manufactured by Galderma. Sculptra® is FDA-approved for restoration of facial fat loss in people with HIV; Sculptra® Aesthetic is FDA-approved for correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles, with cheek wrinkles added in 2023, in immune-competent people. Both indications are facial, and buttock use is off-label. The FDA has issued a safety communication advising against injectable filler for large-scale body contouring, including the buttocks.
Sterile Water for Injection, with lidocaine hydrochloride added — Buttock technique uses roughly 16 to 20 mL of dilution per vial against about 8 mL for facial technique, because the suspension has to spread across a wide surface. Adding lidocaine to the reconstitution is an off-label modification of the labeled preparation and is widely described in published injector consensus guidance.
Blunt-tip cannula — A blunt tip is used to keep the plane consistent and to reduce vascular entry. Injection into the gluteal muscle is not performed here at any dose or dilution.
Hyaluronidase — Hyaluronidase dissolves hyaluronic acid gels only. Poly-L-lactic acid is not reversible, which is the reason this treatment is staged in small increments across several months rather than delivered in one large session.
Tissue sits differently once the muscle is loaded, so we look standing. We ask about any prior injection.
You sign knowing exactly what the FDA has and has not reviewed. Buttock use is named as off-label in writing before anything is opened. Vials are reconstituted with sterile water in advance, following the labeled hydration time, at a volume calculated for the surface area being treated, with lidocaine added shortly before injection.
Entry points are numbed. A blunt cannula fans the suspension through the fat, above the muscle.
The next session sits 6 to 8 weeks out, so this collagen appears first.
The buttock looks fuller walking out: fluid, gone in three days. Soreness lasts 3 to 5 days.
Give this six weeks before you go looking for anything. Change builds between month three and six after the final session.
In the facial studies, effect persisted to about 25 months. Durability in the buttock is not established in labeled data, so plans are made on roughly two years and a maintenance session.
No, they are different decisions. A Brazilian butt lift transfers the patient's own fat in an operating room, so volume moves on the day. A Sculptra® butt lift injects poly-L-lactic acid, which prompts collagen over months.
No, and you should have that plainly. Sculptra® is approved by the U.S. Food and Drug Administration for facial fat loss in people with HIV, and Sculptra® Aesthetic for nasolabial folds and other facial wrinkles, with cheek wrinkles added in 2023, in immune-competent people, so buttock treatment is off-label: the product is the same, and that particular use has not been through approval. The FDA has also issued a safety communication advising against injectable filler for large-scale body contouring, including the buttocks, and that document is part of the consultation. You are welcome to read it before you decide anything.
Most plans run 8 to 16 vials, across 3 to 4 sessions six to eight weeks apart. The count follows surface area and subcutaneous thickness. Plans open at the low end: vials can be added, never taken back.
The cost depends on your treatment plan. Call (614) 425-1633 for current pricing and ask what consultation, treatment, and follow-up charges apply.
Plan on roughly two years and a maintenance session. In the facial studies behind the product, effect persisted to about 25 months, which is the durability figure carried in the labeling, and durability in the buttock has not been established in labeled studies — so treat two years as a planning number rather than a promise. The collagen resorbs gradually rather than ending on a date, and weight change moves the interval in either direction.
Slightly, in most cases. A Sculptra® butt lift reads as firmer, rounder and smoother rather than larger. A few millimetres of collagen across a wide surface changes shape more than size. A goal stated in inches describes volume.
Most patients describe pressure rather than sharp pain. Lidocaine is mixed into the dilution and the entry points are numbed. You can sit down immediately and drive yourself home. Expect soreness for 3 to 5 days.
No, and that is the trade. Poly-L-lactic acid is not reversible, and hyaluronidase, the enzyme that dissolves hyaluronic acid filler, has no effect on it. That is why the treatment is staged: a result can be added to, and not subtracted from.
Bruising, swelling, tenderness and firmness settle within a week. The one worth understanding is delayed-onset nodules: collagen collections appearing weeks or months later, more likely with under-dilution, uneven placement or skipped massage. Infection and delayed granuloma are uncommon.
Nothing bad happens. Stopping returns the tissue to its own trajectory: the collagen built resorbs gradually and the area returns to where it would have been. No rebound effect has been described.
Sculptra® and Sculptra® Aesthetic are registered trademarks of Galderma. BBL® is a registered trademark of Sciton, Inc. for its BroadBand Light device. This page describes no Sciton product; where the lowercase term “bbl” appears, it reflects the colloquial patient name for buttock augmentation surgery. Rouge Aesthetics is not affiliated with, licensed by, or endorsed by either company.
Sculptra® is approved by the U.S. Food and Drug Administration for facial fat loss in people with HIV, and Sculptra® Aesthetic for nasolabial folds and other facial wrinkles, with cheek wrinkles added in 2023, in immune-competent people. Treatment of the buttock is an off-label use, and the FDA has issued a safety communication advising against the use of injectable filler for large-scale body contouring or enhancement, including the buttocks. We discuss that document before you consent.
This page is general information, not medical advice. Individual results vary, poly-L-lactic acid is not reversible, and treatment requires an in-person consultation and a medical eligibility review. Treatment is provided only where it is indicated.
Rouge Aesthetics · 101 Mill Street, Suite 210, Gahanna, OH 43230 · (614) 425-1633
Individual results vary. This website provides general information and does not replace an individual consultation.